Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation

Wynn, 2008, Cellular and molecular mechanisms of fibrosis, J. Pathol., 214, 199, 10.1002/path.2277 Iredale, 2007, Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ, J. Clin. Invest., 117, 539, 10.1172/JCI30542 Leon, 2006, Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data, Lancet, 367, 52, 10.1016/S0140-6736(06)67924-5 D'Ambrosio, 2012, A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis, Hepatology, 56, 532, 10.1002/hep.25606 Iredale, 2001, Hepatic stellate cell behaviour during resolution of liver fibrosis, Semin. Liver Dis., 21, 427, 10.1055/s-2001-17557 Dufour, 1997, Reversibility of hepatic fibrosis in autoimmune hepatitis, Ann. Intern. Med., 127, 981, 10.7326/0003-4819-127-11-199712010-00006 Dienstag, 2003, Histological outcome during long-term lamiduvine therapy, Gastroenterology, 124, 105, 10.1053/gast.2003.50013 Poynard, 2002, Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C, Gastroenterology, 122, 1303, 10.1053/gast.2002.33023 Hammel, 2001, Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct, N. Engl. J. Med., 344, 418, 10.1056/NEJM200102083440604 Geerts, 2001, History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells, Semin. Liver Dis., 21, 311, 10.1055/s-2001-17550 Maher, 1988, Collagen measured in primary cultures of normal rat hepatocytes derives from lipocytes within the monolayer, J. Clin. Invest., 82, 450, 10.1172/JCI113618 de Leeuw, 1984, Purified rat liver fat-storing cells in culture divide and contain collagen, Hepatology, 4, 392, 10.1002/hep.1840040307 Murphy, 2002, Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis, J. Biol. Chem., 277, 11069, 10.1074/jbc.M111490200 Iredale, 1996, Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis, Hepatology, 24, 176, 10.1002/hep.510240129 Benyon, 1996, Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver, Gastroenterology, 110, 821, 10.1053/gast.1996.v110.pm8608892 Henderson, 2007, Liver fibrosis: cellular mechanisms of progression and resolution, Clin. Sci. (Lond.), 112, 265, 10.1042/CS20060242 Duffield, 2005, Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair, J. Clin. Invest., 115, 56, 10.1172/JCI200522675 Schuppan, 1992, The extracellular matrix in cellular communications Friedman, 1993, The cellular basis of hepatic fibrosis, N. Engl. J. Med., 328, 1828, 10.1056/NEJM199306243282508 Friedman, 1985, Hepatic lipocytes: the principal collagen-producing cells of normal rat liver, Proc. Natl. Acad. Sci., 82, 8681, 10.1073/pnas.82.24.8681 Maher, 1988, Immunolocalization of laminin in normal rat liver and biosynthesis of laminin by hepatic lipocytes in primary culture, Gastroenterology, 94, 1053, 10.1016/0016-5085(88)90566-5 Issa, 2004, Spontaneous recovery from micronodular cirrhosis: evidence for incomplete resolution associated with matrix cross-linking, Gastroenterology, 126, 1795, 10.1053/j.gastro.2004.03.009 Zhang, 2012, Fibrosis-dependent mechanisms of hepatocarcinogenesis, Hepatology, 56, 769, 10.1002/hep.25670 Mak, 1988, Lipocytes and transitional cells in alcoholic liver disease: a morphometric study, Hepatology, 8, 1027, 10.1002/hep.1840080508 Maher, 1990, Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo, J. Clin. Invest., 86, 1641, 10.1172/JCI114886 Milani, 1989, In situ hybridization for procollagen types I, III and IV mRNA in normal and fibrotic rat liver: evidence for predominant expression in nonparenchymal liver cells, Hepatology, 10, 84, 10.1002/hep.1840100117 Pellicoro, 2012, Elastin accumulation is regulated at the level of degradation by macrophage metalloelastase (MMP-12) during experimental liver fibrosis, Hepatology, 55, 1965, 10.1002/hep.25567 Asahina, 2011, Septum transversum-derived mesothelium gives rise to hepatic stellate cells and perivascular mesenchymal cells in developing mouse liver, Hepatology, 53, 983, 10.1002/hep.24119 Forbes, 2004, A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis, Gastroenterology, 126, 955, 10.1053/j.gastro.2004.02.025 Russo, 2006, The bone marrow functionally contributes to liver fibrosis, Gastroenterology, 130, 1807, 10.1053/j.gastro.2006.01.036 Kisseleva, 2006, Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis, J. Hepatol., 45, 429, 10.1016/j.jhep.2006.04.014 Kinnman, 2002, Peribiliary myofibroblasts in biliary type liver fibrosis, Front. Biosci., 7, 496, 10.2741/kinnman Knittel, 1999, Rat liver myofibroblasts and hepatic stellate cells: different cell populations of the fibroblast lineage with fibrogenic potential, Gastroenterology, 117, 1205, 10.1016/S0016-5085(99)70407-5 Taura, 2010, Hepatocytes do not undergo epithelial–mesenchymal transition in liver fibrosis in mice, Hepatology, 51, 1027, 10.1002/hep.23368 Scholten, 2010, Genetic labelling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice, Gastroenterology, 139, 987, 10.1053/j.gastro.2010.05.005 Chu, 2011, Lineage tracing demonstrates no evidence of cholangiocyte epithelial-to-mesenchymal transition in murine models of hepatic fibrosis, Hepatology, 53, 1685, 10.1002/hep.24206 Friedman, 2008, Hepatic stellate cells: protean, multifunction, and enigmatic cells of the liver, Physiol. Rev., 88, 125, 10.1152/physrev.00013.2007 Gressner, 2002, Roles of TGF-beta in hepatic fibrosis, Front. Biosci., 7, d793, 10.2741/gressner Pinzani, 1989, Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells, J. Clin. Invest., 84, 1786, 10.1172/JCI114363 Olsen, 2011, Hepatic stellate cells require a stiff environment for myofibroblastic differentiation, Am. J. Phyiol. Gastrointest. Liver Physiol., 301, G110, 10.1152/ajpgi.00412.2010 Iredale, 1997, Tissue inhibitors of metalloproteinases in liver fibrosis, Int. J. Biochem. Cell Biol., 29, 43, 10.1016/S1357-2725(96)00118-5 Siller-López, 2004, Treatment with human metalloproteinase-8 gene delivery ameliorates experimental rat liver cirrhosis, Gastroenterology, 126, 1122, 10.1053/j.gastro.2003.12.045 Fallowfield, 2007, Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis, J. Immunol., 178, 5288, 10.4049/jimmunol.178.8.5288 Matrisian, 1992, The matrix-degrading metalloproteinases, Bioessays, 14, 455, 10.1002/bies.950140705 Murphy, 1992, The matrix metalloproteinases and their inhibitors, Am. J. Respir. Cell Mol. Biol., 7, 120, 10.1165/ajrcmb/7.2.120 Kendall, 2009, p75 Neurotrophin receptor signalling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis, Hepatology, 49, 901, 10.1002/hep.22701 Vyas, 1995, Rat hepatic lipocytes synthesize and secrete transin (stomelysin) in early primary culture, Gastroenterology, 109, 889, 10.1016/0016-5085(95)90399-2 Winwood, 1995, Kupffer cell-derived 950kd type IV collagenase/gelatinase B: characterization and expression in cultures cells, Hepatology, 22, 304 Arthur, 1989, Lipocytes from normal rat liver release a neutral metalloproteinase that degrades basement membrane (type IV) collagen, J. Clin. Invest., 84, 1076, 10.1172/JCI114270 Arthur, 1992, Secretion of 72kDA type IV collagenase/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity, Biochem. J., 287, 701, 10.1042/bj2870701 Benyon, 1999, Progelatinase A is produced and activated by rat hepatic stellate cells and promotes their proliferation, Hepatology, 30, 977, 10.1002/hep.510300431 Okazaki, 1974, Collagenase activity in experimental hepatic fibrosis, Nature, 252, 49, 10.1038/252049a0 Perez-Tamayo, 1987, Collagenolytic activity in experimental cirrhosis of the liver, Exp. Mol. Pathol., 47, 300, 10.1016/0014-4800(87)90015-3 Maruyama, 1981, Direct measurement of neutral collagenase activity in homogenates from baboon and human liver, Biochim. Biophys. Acta, 658, 124, 10.1016/0005-2744(81)90255-2 Maruyama, 1982, Mammalian collagenase increases in early alcoholic liver disease and decreases with cirrhosis, Life Sci., 30, 1379, 10.1016/0024-3205(82)90023-6 Issa, 2001, Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors, Gut, 48, 548, 10.1136/gut.48.4.548 Wright, 2001, Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats, Gastroenterology, 121, 685, 10.1053/gast.2001.27188 Alkhouri, 2011, A combination of the pediatric NAFLD fibrosis index and enhanced liver fibrosis test identifies children with fibrosis, Clin. Gastroenterol. Hepatol., 9, 150, 10.1016/j.cgh.2010.09.015 Parkes, 2010, Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease, Gut, 59, 1245, 10.1136/gut.2009.203166 Rosenberg, 2004, Serum markers detect the presence of liver fibrosis: a cohort study, Gastroenterology, 127, 1704, 10.1053/j.gastro.2004.08.052 Iredale, 1992, Human hepatic lipocytes synthesize tissue inhibitor of metalloproteinases-1. Implications for regulation of matrix degradation in liver, J. Clin. Invest., 90, 282, 10.1172/JCI115850 Yoshiji, 2000, Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model, Hepatology, 32, 1248, 10.1053/jhep.2000.20521 Yoshiji, 2002, Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse, Hepatology, 36, 850, 10.1053/jhep.2002.35625 Issa, 2003, Mutation in collagen-1 that confers resistance to the action of collagenase results in failure of recovery from CCl4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration, FASEB J., 17, 47, 10.1096/fj.02-0494fje Parsons, 2004, Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats, Hepatology, 40, 1106, 10.1002/hep.20425 Roeb, 2000, An MMP-9 mutant without gelatinolytic activity as a novel TIMP-1 antagonist, FASEB J., 14, 1671, 10.1096/fj.99-0947fje Roderfeld, 2006, Inhibition of hepatic fibrogenesis by matrix metalloproteinase-9 mutants in mice, FASEB J., 20, 444, 10.1096/fj.05-4828com Desmet, 2004, Cirrhosis reversal: a duel between dogma and myth, J. Hepatol., 40, 860, 10.1016/j.jhep.2004.03.007 Wanless, 2000, Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis, Ach. Pathol, Lab. Med., 124, 1599 Fallowfield, 2011, Therapeutic targets in liver fibrosis, Am. J. Physiol. Gastrointest. Liver Physiol., 300, G709, 10.1152/ajpgi.00451.2010 Popov, 2011, Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice, Gastroenterology, 140, 1642, 10.1053/j.gastro.2011.01.040 Barry-Hamilton, 2010, Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment, Nat. Med., 16, 1009, 10.1038/nm.2208 Kisseleva, 2012, Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis, Proc. Natl. Acad. Sci. U. S. A., 109, 9448, 10.1073/pnas.1201840109 Troeger, 2012, Deactivation of hepatic stellate cells during liver fibrosis resolution in mice, Gastroenterology, 143, 1073, 10.1053/j.gastro.2012.06.036 Henderson, 2012, Standing down the guard: stellate cells leave quietly, Gastroenterology, 143, 890, 10.1053/j.gastro.2012.08.014 Jiao, 2012, Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression, Hepatology, 55, 244, 10.1002/hep.24621 Thomas, 2011, Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration and function, Hepatology, 53, 2003, 10.1002/hep.24315 Boulter, 2012, Macrophage-derived Wnt opposes Notch signalling to specify hepatic progenitor cell fate in chronic liver disease, Nat. Med., 18, 572, 10.1038/nm.2667 Baker, 1994, Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis, J. Clin. Invest., 94, 2105, 10.1172/JCI117565 Adamczak, 2003, Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomised rats, J. Am. Soc. Nephrol., 14, 2833, 10.1097/01.ASN.0000095248.91994.D3 Cochrane, 2005, Renal structural and functional repair in a mouse model of reversal of ureteral obstruction, J. Am. Soc. Nephrol., 16, 3623, 10.1681/ASN.2004090771 Fioretto, 1998, Reversal of lesions of diabetic nephropathy after pancreas transplantation, N. Engl. J. Med., 339, 69, 10.1056/NEJM199807093390202 Fioretto, 2006, Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients, Kidney Int., 69, 907, 10.1038/sj.ki.5000153 Berk, 2007, ECM remodelling in hypertensive heart disease, J. Clin. Invest., 117, 568, 10.1172/JCI31044